# 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

> **NCT05875753** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI-FS PET/CT

## Key facts

- **NCT ID:** NCT05875753
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05875753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05875753, "68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05875753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*